Home > Boards > US OTC > Miscellaneous >

Nascent Biotech Inc. (NBIO)

Add NBIO Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 9/12/2019 9:57:11 AM - Followers: 16 - Board type: Free - Posts Today: 0


Download the full Investors presentation here:

Nascent Biotech to Sponsor Human Antibodies & Hybridomas Conference

April 4, 2018/in Corporate News /

This October 22-24, 2018, in Riga, Latvia, Human Antibodies & Hybridomas Magazine will present its annual conference. Nascent Biotech will be one of the event’s primary sponsors, with Nascent Biotech founder Dr. Mark Glassy serving as the program chairman.

Click this link to download a PDF detailing the conference details, and how to register.

Nascent Biotech Inc. (OTCQB: NBIO)

Nascent Biotech is a development stage biopharmaceutical company that develops monoclonal antibodies for the treatment of various forms of cancer. The company focuses on biologic drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company is primarily focused on developing pritumumab for the treatment of patients with brain cancer malignancies such as glioma and astrocytoma. Pritumumab is a monoclonal antibody that has been tested in Ministry of Health and Welfare approved clinical studies in 249 human brain cancer patients in the nation of Japan. The objective of the Phase I and Phase II human clinical trial was to determine the safety of pritumumab in humans and its efficacy in eliminating tumors or reducing tumor size in patients with brain cancer.


Share Structure

Market Cap
Authorized Shares
Outstanding Shares
Held at DTC
Par Value

Recent News




Nascent Biotech Significant Milestones Achieved since 2015

  • Re-engineered antibody into CHO cells:     The original cell line was created as a Hybridoma.  Manufacturing from the Hybridoma cell line was a prohibitively expensive very process.  A recombinant form was created that secretes over 40 fold more antibodies.    
    Created and fully characterized and qualified Master Cell Bank (MCB):
    Produced 400+ grams of GMP grade mAb:  This is a key inflection point with Biotech Investors which mitigates manufacturing risk.  Formulation studies show that the antibodies are stable.
    Pre-IND and clinical protocol discussions with FDA:  There were no preclinical issues and the FDA provided guidance for our Study Protocol which increases the probability that we will gain IND approval on the first attempt.   This also mitigates IND trial delays.       
    Settled $1.7M debt to license holder
    Retired debenture – eliminating 30% shareholder dilution.
    Finished in life phase toxicology studies (monkey and rat):  “This is the easiest study I have ever seen.  I wish all my Toxicology Studies went this well,” Fred Reno-Toxicology trial consultant.  Completing the toxicology study mitigates toxicology issues.  Nascent had none.       
    Completed Viral Clearance study – Significantly exceeds FDA recommendations.
    Completed Fill and Finish of purified bulk product.
    Filed IND Application April 2017 – Finalizing FDA requested studies.  Plan to refile by mid Q 1 2018 (FDA requested a new Viral Clearance Study and a Tox/Clinical lot Comparative Analysis).
    Signed $16 Million licensing deal with Hisun Pharmaceuticals for Mainland China - $ 3 million received in upfront payment – Saved investors significant dilution.
    Raised $1.45 Million in equity investment – no debt financing.
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#541   $NBIO a biopharmaceutical company focusing on the development ireed 09/12/19 09:57:11 AM
#540   While today's news is a positive step, it Craig305 08/19/19 03:09:42 PM
#539   I see it now. IPO$ 08/19/19 02:57:59 PM
#538   I don’t see any news out there. IPO$ 08/19/19 02:55:45 PM
#537   Phase 1....news released today. Craig305 08/19/19 02:52:27 PM
#536   What stage of FDA are they at? IPO$ 08/17/19 08:34:50 AM
#535   Volume yesterday. IPO$ 08/17/19 08:33:37 AM
#534   Who ever sold today at 0.17 is a rrao11 07/01/19 08:15:07 PM
#533   Good find. This is as good as rrao11 06/07/19 06:49:16 AM
#532   Great news yesterday. A move and FDA news Captain Hindsight 06/06/19 09:41:06 AM
#531   Its ready, just needs a push. Moves on Captain Hindsight 05/22/19 09:48:47 AM
#530   $NBIO 3 months chart $Pistol Pete$ 05/21/19 02:03:15 PM
#529   This is primed and ready for a massive run. Captain Hindsight 05/14/19 02:16:45 PM
#528   Anything Going On In Here? $nbio BayTrader280 04/12/19 10:46:29 AM
#527   CDEL is literally the only thing holding $NBIO Captain Hindsight 07/10/18 09:40:31 AM
#526   Volume coming in today!!!! The big push over Captain Hindsight 07/09/18 04:01:15 PM
#525   NBIO ***Alert*** $NBIO ***Pounding The Table***$NBIO 2 Cancer Drugs Captain Hindsight 07/08/18 11:30:10 PM
#524   The weeks ahead will be epic! This is Captain Hindsight 06/15/18 08:39:09 PM
#523   I truly believe $NBIO is going to go Captain Hindsight 06/12/18 10:30:34 PM
#522   Great day here. One day soon I wont Captain Hindsight 06/11/18 04:05:31 PM
#521   Active OTCQB 2018. Clinical trials being conducted as Captain Hindsight 06/08/18 09:01:32 AM
#520   Nascent Biotech to Sponsor Human Antibodies & Hybridomas Captain Hindsight 06/07/18 01:59:58 PM
#519   Something is brewing here. Captain Hindsight 06/04/18 10:20:00 AM
#518   $NBIO, its about to get weird fellas. Captain Hindsight 06/04/18 10:13:53 AM
#517   Senior Execs adding shares here. Hmmm..... Lone Wolf 10/10/17 07:41:45 AM
#516   not the same company apparently.The other ticker is bakinfive53 09/26/14 11:06:13 AM
#515   JinZangHuang Tibet Pharmaceuticals changed to Nascent Biotech Inc., NBIO: Renee 09/24/14 05:55:46 PM
#513   JZHG Chart JoeyMiggs 09/04/14 04:43:14 PM
#512   BUY AND HOLD TIL .02 jas2 08/12/14 12:25:21 PM
#511   They will bounce back up, no doubt. IMO. jas2 08/12/14 11:41:26 AM
#510   Prob complete fraud LaorgeMONEY 08/11/14 10:49:40 PM
#509   Chinese P&D. Everyone knows what that means! bar1080 08/11/14 04:35:35 PM
#508   What a stinker this has been. Make way bar1080 08/11/14 04:33:47 PM
#507   Is this another one of those pump and dumpers? jas2 08/11/14 01:47:07 PM
#506   Look at their homepage at http://www.usjzh.com/ nano1972 08/11/14 12:00:55 PM
#505   $JZHG recent news/filings stocktrademan 08/11/14 10:01:46 AM
#504   JZHG - Promo Going on. Caveat Emptor! Link Below!!! Chrion Capital 08/11/14 06:33:53 AM
#503   JZHG:Daily Chart - On Watch Chrion Capital 08/11/14 06:30:38 AM
#502   DDAmanda Chart on: $JZHG: Click on chart twice ZarGhost 08/10/14 12:43:14 PM
#501   go TradeMe 08/08/14 09:50:43 AM
#500   ~JZHG~ weeeeeee ! what a nice friday surprise :) SILVERISTHENEWGOLD 08/08/14 09:42:27 AM
#499   JZHG promotion starting today. raquel24 08/08/14 09:30:43 AM
#498   Looks like potential JZHG LaorgeMONEY 07/18/14 07:52:50 AM
#497   Horrible market volume, panic selling on downtrend, just SILVERISTHENEWGOLD 07/17/14 12:45:09 PM
#496   Y? There are so many sellers. nano1972 07/17/14 12:43:24 PM
#495   ~JZHG~ Looks like breakout coming here SILVERISTHENEWGOLD 07/17/14 09:48:18 AM
#494   I couldn't get the information on that site. pack10 07/08/14 05:54:26 PM
#493   But there was a filling on 03 12 nano1972 07/08/14 11:31:39 AM
#492   Nine months and 7 days since we heard pack10 07/07/14 09:26:05 AM
#491   ~JZHG~ Buying 0107's ~ HUGE NET ASSETS~ RECENT 8-K SILVERISTHENEWGOLD 05/16/14 01:59:13 PM